138 related articles for article (PubMed ID: 9347771)
1. Terfenadine and SSRIs.
Tafler G
CMAJ; 1997 Oct; 157(8):1019. PubMed ID: 9347771
[No Abstract] [Full Text] [Related]
2. Drug interactions, cardiac toxicity, and terfenadine: from bench to clinic?
Flockhart DA
J Clin Psychopharmacol; 1996 Apr; 16(2):101-3. PubMed ID: 8690824
[No Abstract] [Full Text] [Related]
3. Drug interactions associated with terfenadine and related nonsedating antihistamines.
Zechnich AD; Haxby DG
West J Med; 1996 Jan; 164(1):68-9. PubMed ID: 8779212
[No Abstract] [Full Text] [Related]
4. [Drug side effects and their prevention].
Hautarzt; 1997 Aug; 48(8 Suppl):3-4. PubMed ID: 9378645
[No Abstract] [Full Text] [Related]
5. Antihistamines and the heart.
Marquardt D
West J Med; 1993 Jun; 158(6):613-4. PubMed ID: 8101675
[No Abstract] [Full Text] [Related]
6. QT lengthening and life-threatening arrhythmias associated with fexofenadine.
Craig-McFeely PM; Freemantle SL; Pearce GL; Shakir SA
Br J Gen Pract; 2000 Feb; 50(451):148. PubMed ID: 10750216
[No Abstract] [Full Text] [Related]
7. Causality assessment of adverse drug effects: when is rechallenge ethically acceptable?
Po AL; Kendall MJ
Lancet; 1999 Aug; 354(9179):683. PubMed ID: 10466699
[No Abstract] [Full Text] [Related]
8. Dangers of non-sedating antihistamines.
Clark S
Lancet; 1997 May; 349(9061):1268. PubMed ID: 9142059
[No Abstract] [Full Text] [Related]
9. Dangers of non-sedating antihistamines.
Himmel MH; Honig PK; Worobec AS
Lancet; 1997 Jul; 350(9070):69; author reply 69-70. PubMed ID: 9217741
[No Abstract] [Full Text] [Related]
10. Prolonged QTc time and ventricular arrhythmia with fexofenadine.
Kashyap AS; Kashyap S
Am J Cardiol; 1999 Nov; 84(10):1278-9. PubMed ID: 10569349
[No Abstract] [Full Text] [Related]
11. Terfenadine-associated ventricular arrhythmias and QTc interval prolongation. A retrospective cohort comparison with other antihistamines among members of a health maintenance organization.
Hanrahan JP; Choo PW; Carlson W; Greineder D; Faich GA; Platt R
Ann Epidemiol; 1995 May; 5(3):201-9. PubMed ID: 7606309
[TBL] [Abstract][Full Text] [Related]
12. Terfenadine should be withdrawn from clinical use.
Khilnani G
J Assoc Physicians India; 1999 Sep; 47(9):943. PubMed ID: 10778682
[No Abstract] [Full Text] [Related]
13. FDA announces plan to halt marketing of terfenadine.
Am J Health Syst Pharm; 1997 Feb; 54(4):342. PubMed ID: 9043551
[No Abstract] [Full Text] [Related]
14. Terfenadine therapy: can we justify the risks?
Rangno R
CMAJ; 1997 Jul; 157(1):37-8. PubMed ID: 9220940
[No Abstract] [Full Text] [Related]
15. [Risk of drug interactions. Combinations of drugs associated with ventricular arrhythmias].
Viramontes-Madrid JL; Jerjes-Sánchez C; Pelaez-Ballestas I; Aguilar-Chiu A; Hernández-Garduño AG
Rev Invest Clin; 2002; 54(3):192-7. PubMed ID: 12183887
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: relation to pharmacokinetic interactions in vivo.
von Moltke LL; Greenblatt DJ; Duan SX; Harmatz JS; Wright CE; Shader RI
J Clin Psychopharmacol; 1996 Apr; 16(2):104-12. PubMed ID: 8690825
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxicity of new antihistamines and cisapride.
Paakkari I
Toxicol Lett; 2002 Feb; 127(1-3):279-84. PubMed ID: 12052668
[TBL] [Abstract][Full Text] [Related]
18. Use of terfenadine and contraindicated drugs.
Zechnich AD; Hedges JR
JAMA; 1996 Sep; 276(12):953. PubMed ID: 8805725
[No Abstract] [Full Text] [Related]
19. Erythromycin and ketoconazole (Nizoral) associated with terfenadine (Seldane)-induced ventricular arrhythmias.
Wynn RL
Gen Dent; 1993; 41(1):27-9. PubMed ID: 7489857
[No Abstract] [Full Text] [Related]
20. Non-sedating antihistamines and cardiac arrhythmia.
Rankin AC
Lancet; 1997 Oct; 350(9085):1115-6. PubMed ID: 9343494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
